Corcept Therapeutics | CORT - Ebitda

Precio De Mercado
56.37
Cambio Diario
-1.93 -3.31%
Mensual
28.23%
Anual
-24.92%
Q2 Expectativa
55.24




Ebitda Cambio Fecha
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Ardelyx USD 6.02M 447K 2025-12
Aurora Cannabis CAD 18.48M 3.11M 2025-12
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Canopy Growth CAD -2.87M 19.49M 2025-12
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Esperion Therapeutics USD -9.93M 24.99M 2025-09
J&J USD 7.19B 2.32B 2025-12
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Merck USD 6.3B 2.09B 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Novartis USD 5.3B 530M 2026-03
Novartis USD 5.84B 235M 2025-09
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 40.24M 1.53M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Supernus Pharmaceuticals USD 29.23M 19.27M 2026-03
TG Therapeutics USD 51.69M 19M 2025-12